The Dow slid on Friday after the Federal Reserve's plan to rekindle consumer and small business lending fell short of expectations...
Q: On Fast Money’s trader radar we look at the stock that was lighting up screens across Wall Street. Founded over 120 years ago, this company made the first ever First Aid kits and also introduced dental floss. Since then, the company has provided both medical and consumer products, including the popular Neutrogena and Tylenol brands. But today, investors had no need for a headache-reliever, as shares surged on an upgrade at UBS. Who is it?
Stocks were mixed Friday after a strong two-week run as financial stocks continued to struggle as some investors locked in profits. Still, Wall Street could close with its first string of consecutive positive weeks in nearly a year.
The government is moving towards a budget that will raise the national deficit to almost $2 trillion dollars. $2,000,000,000,000. That's a lot of zeroes! Even the Chinese have expressed concern over U.S. deficits. And when the Chinese, the biggest buyer of U.S. debt, begin voice concerns, you know deficits are real and something to be worried about.
US Markets recorded their best week since November, riding four consecutive days of gains, making traders question whether we have found the bottom or if this is merely a bear bounce.
This was a very constructive week, the best weekly advance for the Dow and the S&P 500 since November.
Berkshire Hathaway has lost its AAA credit rating from Fitch, but it doesn't look like the change is due to any recent 'mistakes' by Warren Buffett and his holding company. Almost at the top of its news release on the one-notch downgrade and negative outlook, Fitch says the move is part of a "broader review of insurance and financial services company ratings" due to the "current stressful economic environment."
Shares of Dow component Merck rare getting a nice little shot in the arm this morning on an upgrade by Dr. Tim Anderson at Sanford C. Bernstein. He's putting an "Outperform" or "Buy" rating on MRK and raising his target price three bucks to $30.
Anyone out there who sees hope in the stock market must be on drugs. And I am: Lipitor and Novasc from Pfizer, Vasotec from Merck, and four other pills, all of which I gobble every day to stop myself from blowing a gasket. So let me say, with some personal pill-popping experience, that this may be a great time to buy drug stocks.
The major indices have some distance to go today if they are going to break weekly records. However, there are 4 Dow components that are on track for their best week in at least 40 years...
Standard & Poor's downgraded General Electric, lowering its rating to AA-plus with a stable outlook, down from the top-tier, AAA credit rating it enjoyed. Here are some sobering facts about GE and other big stocks...
Last night on Fast Money, Guy Adami mentioned that "the PE is very compelling" for Hewlett Packard. Many of the PE's for the Dow 30 are at historic lows. Here's a "By the Numbers" look at current PE's and implied valuation.
Cramer makes the call on viewers' favorite stocks.
New Jersey, where I live and work, is known as "The World's Medicine Chest" or "The Silicon Valley of Pharma."
This is part four of the preliminary transcript and video clips of Warren Buffett's appearances on CNBC's Squawk Box on Monday, March 9, 2009.
This is part one of the preliminary transcript and video clips of Warren Buffett's appearances on CNBC's Squawk Box on Monday, March 9, 2009.
Personalized medicine represents a paradigm shift from the “blockbuster” model in drug development that focuses on understanding and crafting treatments for specific diseases, not specific patients, writes Paul Stoffels, M.D., Company Group Chairman, Global Research and Development, Pharmaceuticals, Johnson & Johnson.
As General Electric continues to fall, the company that once boasted a half trillion dollar market cap, is now at risk of falling out of the Top 20 biggest companies in the S&P 500.
Robert Lloyd of the AIM Summit Fund is not banking on a quick recovery in the economy. So what's his investment strategy?
Two months into the year, the average dividend yield of the Dow 30 has continued to rise since the start of 2009, despite some significant dividend cuts like those from CNBC parent, General Electric. See how the 30 companies in the Dow compare.